Seven board members and company insiders dumped a total of $4.3 million worth of Nancy Pelosi's latest stock holding, Tempus ...

Tempus AI stock surged 40% YTD, driven by acquisitions and investor confidence in healthcare AI. Can its momentum spark ...

Artificial Intelligence (AI) and Machine Learning (ML) play a pivotal role in precision oncology, analyzing vast datasets, ...

Cathie Wood’s ARK ETFs made some significant trades on Tuesday, including selling of Meta Platforms’ (META) stock, while boosting its ...

Tempus AI, Inc. (NASDAQ:TEM – Get Free Report) has been given an average rating of “Moderate Buy” by the twelve ratings firms ...

Cathie Wood-led Ark Invest made significant trades involving Tempus AI Inc. TEM, Advanced Micro Devices Inc. AMD, and Meta ...

Detailed price information for Uipath Inc Cl A (PATH-N) from The Globe and Mail including charting and trades.

EDT Cathie Wood’s ARK Investment bought 171K shares of Tempus AI (TEM) todayLight Up your Portfolio with Spark:Easily identify stocks' ...

In the biotech sphere, ARK ETFs continued to accumulate shares of CRISPR Therapeutics AG (NASDAQ: CRSP) and Intellia Therapeutics Inc (NASDAQ: NTLA ), with purchases of 67,787 and 194,844 shares, ...

During a Community Case Forum event in partnership with the Texas Society of Clinical Oncology, Natalie Vokes, MD, discussed trials of targeted agents for EGFR-mutant lung cancer.

Kimia Therapeutics, Inc. (Kimia), a biotechnology company generating a chemical atlas for treating human disease, today announced the appointment of Imran S.

Tempus AI's financials have significantly improved, with positive cash flow expected next quarter. Read why TEM stock is a ...